What labs are used to diagnose hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Diagnosing Hyperparathyroidism

The diagnosis of hyperparathyroidism requires simultaneous measurement of serum calcium and intact parathyroid hormone (iPTH) as the essential laboratory tests. 1

Core Diagnostic Tests

  • Serum calcium (total calcium corrected for albumin) and intact parathyroid hormone (iPTH) should be measured simultaneously to establish the diagnosis 1, 2
  • Serum phosphate levels should be measured as hyperparathyroidism typically causes hypophosphatemia 2
  • 25-hydroxyvitamin D levels must be assessed to exclude vitamin D deficiency as a secondary cause of elevated PTH 3, 2
  • Serum creatinine and blood urea nitrogen (BUN) to evaluate kidney function, as hypercalcemia can affect renal function 3
  • Urine calcium/creatinine ratio in a random spot urine to assess for hypercalciuria 3

Diagnostic Algorithm

  1. Initial screening: Measure serum calcium (corrected for albumin) and iPTH simultaneously 1

    • Primary hyperparathyroidism: Elevated or high-normal calcium with inappropriately normal or elevated PTH 2, 4
    • Secondary hyperparathyroidism: Normal or low calcium with elevated PTH 1
    • Tertiary hyperparathyroidism: Hypercalcemia with elevated PTH (often in end-stage renal disease) 1
  2. Additional tests to confirm diagnosis:

    • Serum phosphate (typically low in primary hyperparathyroidism) 2
    • Calcium-to-creatinine clearance ratio (to rule out familial hypocalciuric hypercalcemia if ratio <0.01) 5
    • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels 3, 5
    • Serum chloride (chloride/phosphate ratio >33 suggests primary hyperparathyroidism) 5

Special Considerations

  • Use assay-specific reference ranges for PTH, as different assay generations measure different PTH fragments 2, 3
  • Be aware that vitamin D deficiency can coexist with and complicate the diagnosis of hyperparathyroidism 3
  • Consider factors that can affect calcium and PTH levels:
    • Race (PTH is higher in Black individuals compared to White individuals) 2
    • Age (PTH increases with age) 2
    • BMI (PTH is higher in obese patients) 2
    • Biotin supplements can interfere with some PTH assays 2, 3

Atypical Presentations

  • Normocalcemic hyperparathyroidism: Normal calcium with elevated PTH (after excluding secondary causes) 6, 7
  • Normohormonal hyperparathyroidism: Elevated calcium with PTH in the normal range 6
  • In cases where both calcium and PTH are within reference ranges but hyperparathyroidism is suspected, a calcium-PTH nomogram may help distinguish between normal patients and those with atypical primary hyperparathyroidism 6

Monitoring Parameters

  • For patients on treatment for secondary hyperparathyroidism, monitor serum calcium and phosphorus monthly for the first 3 months, then every 3 months thereafter 3
  • Serial assessments of phosphate, calcium, and PTH levels should be considered together for ongoing management 3

Common Pitfalls to Avoid

  • Not assessing vitamin D status when interpreting PTH levels 3
  • Using different PTH assay generations without considering their varying sensitivity to PTH fragments 2, 3
  • Failing to correct calcium for albumin levels 1
  • Not considering familial hypocalciuric hypercalcemia in patients with hypercalcemia, normal/elevated PTH, and low urinary calcium excretion 5

References

Guideline

Hyperparathyroidism Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laboratory Evaluation for Hypercalcemia and Elevated iPTH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperparathyroidism: primary or secondary disease?

Reumatologia clinica, 2012

Research

[Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.